However, the frequency of MSI and PTEN alterations in clear cell carcinoma is higher than in serous carcinoma (15% versus <5 for MSI and 30% versus 10% for PTEN) but lower compared with endometrioid carcinoma (20–40% and 35–50%, resp). This evidence concerns the gene PTEN and serous adenocarcinoma.